Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.66 |
| ▸ | FLT3 | P36888 | 2/20 | 0.66 |
| ▸ | MAOB | P27338 | 2/20 | 0.66 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.64 |
| ▸ | PLG | P00747 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1421577 | 0.88 | ABCB1 (0.68) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| SCHEMBL29845342 | 0.83 | CYP1B1 (0.86) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| SCHEMBL1421382 | 0.83 | CYP1B1 (0.86) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| Artocarpetin SCHEMBL676337 | 0.83 | IP6K2 (0.76) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| SCHEMBL16150088 | 0.83 | MAOA (0.85) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| Artocarpetin SCHEMBL29435858 | 0.83 | IP6K2 (0.76) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| SCHEMBL27907057 | 0.82 | CYP1B1 (0.84) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| Methane SCHEMBL27890494 | 0.82 | CYP1B1 (0.84) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| SCHEMBL26679497 | 0.82 | QPCT (0.85) | IP6K2FLT3MAOBMKNK2CYP19A1 | |
| Corymbosin SCHEMBL1976826 | 0.82 | ABCB1 (0.78) | IP6K2FLT3MAOBMKNK2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144194-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | AXOGLIA THERAPEUTICS (LU) | 2011-06-16 | — | — | US | disclosed |
| EP-2112145-A1 | Chromenone derivatives useful for the treatment of neurodegenerative diseases | AxoGlia Therapeutics S.A. (LU) | 2009-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144194-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PARK7, CDR2, SNCA | IP6K2 3930/4885FLT3 4707/4885MAOB 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.